Location: Menlo Park, CA
CIK: 0001631134 · Show all filings
Period: Q1 2020 (← Previous) (Next →)
Filing Date: May 13, 2020
Total Value: $1.081B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Karuna Therapeutics, Inc. | 1,885,602 | $136M | 12.6% | $24.60 | — | COMM | 48576A100 |
| ASND | Ascendis Pharma A/S | 1,109,874 | $125M | 11.6% | $69.98 | — | ADR | 04351P101 |
| — | Nextcure, Inc | 2,671,856 | $99.05M | 9.2% | $17.30 | — | COMM | 65343E108 |
| NTRA | Natera | 3,100,560 | $92.58M | 8.6% | $9.81 | +240.7% | COMM | 632307104 |
| — | Principia Biopharma | 1,417,258 | $84.16M | 7.8% | $28.92 | — | COMM | 74257L108 |
| — | Y-mAbs Therapeutics, Inc | 2,194,278 | $57.27M | 5.3% | $26.75 | — | COMM | 984241109 |
| MRK | Merck & Co Inc | 463,795 | $35.69M | 3.3% | $66.37 | -1.9% | COMM | 58933Y105 |
| CHRS | Coherus BioSciences | 1,933,221 | $31.36M | 2.9% | $10.94 | +68.9% | COMM | 19249H103 |
| GRTX | Galera Therapeutics, Inc | 3,083,712 | $29.3M | 2.7% | $12.19 | +5.7% | COMM | 36338D108 |
| — | Alexion Pharmaceuticals Inc | 307,300 | $27.59M | 2.6% | $89.79 | — | COMM | 015351109 |
| — | Merus N.V. | 1,961,039 | $23.73M | 2.2% | $18.53 | — | COMM | N5749R100 |
| UTHR | United Therapeutics Corp | 233,559 | $22.15M | 2.0% | $83.32 | +14.1% | COMM | 91307C102 |
| — | Amarin | 5,208,305 | $20.83M | 1.9% | $7.81 | — | ADR | 023111206 |
| VRTX | Vertex Pharmaceuticals Inc | 85,664 | $20.38M | 1.9% | $179.35 | +27.9% | COMM | 92532F100 |
| BMRN | Biomarin Pharmaceutical Inc | 240,046 | $20.28M | 1.9% | $77.86 | +10.7% | COMM | 09061G101 |
| BIIB | Biogen Inc | 52,628 | $16.65M | 1.5% | $277.46 | +9.4% | COMM | 09062X103 |
| — | Acceleron Pharma Inc | 165,160 | $14.84M | 1.4% | $45.86 | — | COMM | 00434H108 |
| — | Kiniksa Pharmaceuticals, Ltd | 922,700 | $14.28M | 1.3% | $17.35 | — | COMM CL A | G5269C101 |
| — | Nucana Biomed Ltd | 2,400,000 | $13.99M | 1.3% | $19.00 | — | Ordinary Shares | GB00BYWYV |
| — | Nucana Biomed Ltd | 2,266,666 | $13.21M | 1.2% | $15.80 | — | ADR | 67022C106 |
| PTCT | PTC Therapeutics Inc | 292,217 | $13.04M | 1.2% | $40.82 | +23.3% | COMM | 69366J200 |
| — | ObsEva SA | 4,749,623 | $11.45M | 1.1% | $13.49 | — | COMM | H5861P103 |
| SRPT | Sarepta Therapeutics Inc | 101,603 | $9.938M | 0.9% | $117.59 | -2.8% | COMM | 803607100 |
| — | Kala Pharmaceuticals Inc | 1,114,520 | $9.796M | 0.9% | $6.47 | — | COMM | 483119103 |
| — | MyoKardia Inc | 175,118 | $8.209M | 0.8% | $60.83 | — | COMM | 62857M105 |
| ALGN | Align Technology Inc | 46,500 | $8.089M | 0.7% | $239.46 | 0.0% | COMM | 016255101 |
| — | Gilead Sciences Inc | 100,000 | $7.476M | 0.7% | — | — | Call | 375558903 |
| — | Kala Pharmaceuticals Inc | 737,300 | $6.48M | 0.6% | — | — | Put | 483119953 |
| — | Kadmon Holdings Inc | 1,526,178 | $6.395M | 0.6% | $2.74 | — | COMM | 48283N106 |
| — | Chiasma | 1,630,221 | $5.95M | 0.6% | $1.49 | — | COMM | 16706W102 |
| MIRM | Mirum Pharmaceuticals Inc | 418,589 | $5.86M | 0.5% | $16.41 | 0.0% | COMM | 604749101 |
| HRTX | Heron Therapeutics Inc | 481,608 | $5.654M | 0.5% | $19.50 | -3.6% | COMM | 427746102 |
| PBYI | Puma Biotechnology Inc | 638,026 | $5.385M | 0.5% | $9.72 | 0.0% | COMM | 74587V107 |
| FOLD | Amicus Therapeutics Inc | 525,530 | $4.856M | 0.4% | $12.27 | -22.5% | COMM | 03152W109 |
| — | Iterum Therapeutics | 1,726,514 | $4.679M | 0.4% | $10.89 | — | COMM | G6333L101 |
| — | Iovance Biotherapeutics Inc | 150,000 | $4.491M | 0.4% | — | — | Call | 462260900 |
| AXSM | Axsome Therapeutics Inc | 73,163 | $4.304M | 0.4% | $81.48 | 0.0% | COMM | 05464T104 |
| ABBV | Abbvie Inc | 50,000 | $3.81M | 0.4% | $67.19 | 0.0% | COMM | 00287Y109 |
| — | Blueprint Medicines Corp | 63,100 | $3.69M | 0.3% | $58.48 | — | COMM | 09627Y109 |
| — | Calithera Biosciences Inc | 819,002 | $3.636M | 0.3% | $4.27 | — | COMM | 13089P101 |
| — | Homology Medicines Inc | 230,663 | $3.584M | 0.3% | $16.25 | — | COMM | 438083107 |
| — | Applied Genetic Technologies Corp | 1,062,615 | $3.485M | 0.3% | $3.28 | — | COMM | 03820J100 |
| — | Akero Therapeutics Inc | 150,000 | $3.18M | 0.3% | — | — | Put | 00973Y958 |
| — | Akero Therapeutics Inc | 148,415 | $3.146M | 0.3% | $21.20 | — | COMM | 00973Y108 |
| — | Entasis Therapeutics Holdings Inc. | 1,180,178 | $3.119M | 0.3% | $10.88 | — | COMM | 293614103 |
| — | Otonomy Inc | 1,515,629 | $2.986M | 0.3% | $2.85 | — | COMM | 68906L105 |
| — | Alnylam Pharmaceuticals Inc | 27,100 | $2.949M | 0.3% | — | — | Call | 02043Q907 |
| TGTX | TG Therapeutics Inc | 275,305 | $2.709M | 0.3% | $6.96 | +81.4% | COMM | 88322Q108 |
| — | ChemoCentryx Inc | 66,695 | $2.68M | 0.2% | $39.55 | — | COMM | 16383L106 |
| — | Rigel Pharmaceuticals Inc | 1,446,318 | $2.257M | 0.2% | $1.56 | — | COMM | 766559603 |
| — | PTC Therapeutics Inc | 50,000 | $2.23M | 0.2% | — | — | Call | 69366J900 |
| CGEN | Compugen Ltd | 300,000 | $2.178M | 0.2% | $7.86 | 0.0% | COMM | M25722105 |
| — | SAGE Therapeutics Inc | 74,430 | $2.138M | 0.2% | $28.72 | — | COMM | 78667J108 |
| ACRS | Aclaris Therapeutics | 1,911,573 | $1.988M | 0.2% | $19.07 | -92.9% | COMM | 00461U105 |
| — | Zymeworks Inc | 49,989 | $1.774M | 0.2% | $22.00 | — | COMM | 98985W102 |
| BCRX | BioCryst Pharmaceuticals Inc | 815,690 | $1.632M | 0.2% | $3.23 | -14.9% | COMM | 09058V103 |
| — | Menlo Therapeutics Inc | 604,829 | $1.621M | 0.1% | $2.68 | — | COMM | 586858102 |
| APLS | Apellis Pharmaceuticals, Inc | 49,580 | $1.328M | 0.1% | $19.65 | +80.6% | COMM | 03753U106 |
| — | Mersana Therapeutics Inc | 225,000 | $1.312M | 0.1% | $5.83 | — | COMM | 59045L106 |
| — | Synlogic Inc. | 574,972 | $989K | 0.1% | $9.38 | — | COMM | 87166L100 |
| — | Zogenix Inc | 32,983 | $816K | 0.1% | $24.74 | — | COMM | 98978L204 |
| FATE | Fate Therapeutics Inc | 36,564 | $812K | 0.1% | $17.86 | +41.6% | COMM | 31189P102 |
| — | Intra-Cellular Therapies Inc | 52,005 | $800K | 0.1% | $15.38 | — | COMM | 46116X101 |
| PDSB | PDS Biotechnology Corporation | 142,635 | $104K | 0.0% | $8.36 | -79.3% | COMM | 70465T107 |